全文获取类型
收费全文 | 3831篇 |
免费 | 392篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 43篇 |
儿科学 | 153篇 |
妇产科学 | 64篇 |
基础医学 | 468篇 |
口腔科学 | 77篇 |
临床医学 | 521篇 |
内科学 | 751篇 |
皮肤病学 | 40篇 |
神经病学 | 337篇 |
特种医学 | 319篇 |
外国民族医学 | 1篇 |
外科学 | 515篇 |
综合类 | 111篇 |
预防医学 | 322篇 |
眼科学 | 32篇 |
药学 | 265篇 |
中国医学 | 6篇 |
肿瘤学 | 221篇 |
出版年
2022年 | 39篇 |
2021年 | 100篇 |
2020年 | 53篇 |
2019年 | 62篇 |
2018年 | 121篇 |
2017年 | 83篇 |
2016年 | 88篇 |
2015年 | 95篇 |
2014年 | 122篇 |
2013年 | 201篇 |
2012年 | 192篇 |
2011年 | 235篇 |
2010年 | 154篇 |
2009年 | 148篇 |
2008年 | 156篇 |
2007年 | 211篇 |
2006年 | 164篇 |
2005年 | 180篇 |
2004年 | 142篇 |
2003年 | 114篇 |
2002年 | 128篇 |
2001年 | 85篇 |
2000年 | 76篇 |
1999年 | 62篇 |
1998年 | 96篇 |
1997年 | 83篇 |
1996年 | 73篇 |
1995年 | 67篇 |
1994年 | 38篇 |
1993年 | 57篇 |
1992年 | 52篇 |
1991年 | 56篇 |
1990年 | 44篇 |
1989年 | 42篇 |
1988年 | 60篇 |
1987年 | 51篇 |
1986年 | 41篇 |
1985年 | 31篇 |
1984年 | 47篇 |
1983年 | 44篇 |
1982年 | 15篇 |
1981年 | 36篇 |
1980年 | 19篇 |
1979年 | 29篇 |
1978年 | 22篇 |
1977年 | 38篇 |
1976年 | 28篇 |
1975年 | 16篇 |
1974年 | 15篇 |
1973年 | 18篇 |
排序方式: 共有4246条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
Drew T. Marshall John D. Gilbert Roger W. Byard 《Forensic science, medicine, and pathology》2007,3(1):53-55
A 26-year-old man who presented with a 2-year history of intermittent gynecomastia with recent onset of fever, night sweats,
and abdominal distension was found to have a left-sided adrenocortical carcinoma with metastases to the liver and spine. Sudden
death occurred 1 month after his presentation. At autopsy a saddle pulmonary thromboembolus was found occluding the pulmonary
outflow tract, with smaller more peripheral pulmonary thromboemboli. No tumor deposits were identified in the thromboemboli.
The thromboemboli had arisen from a tongue of tumor that had grown through the left adrenal vein into the inferior vena cava.
Despite a high rate of angio-invasion there are very few reports of sudden death resulting from this phenomenon in patients
with adrenocortical carcinoma. 相似文献
8.
Kevin G Becker Insong J Lee James W Nagle Rachel D Canning Ameer M Gado Rosarelis Torres Mihael H Polymeropoulos Paul T Massa WilliamE Biddison Paul D Drew 《International journal of developmental neuroscience》1997,15(7):73
We describe a novel human zinc finger cNDA, C2H2-171. This cDNA represents an mRNA which encodes a protein of 484 amino acids and a calculated molecular weight of 54 kD. Four zinc finger-like domains are found in the C-terminal end of the protein. At the N-terminus, C2H2-171 contains a POZ/tramtrack-like domain similar to that found in the tumor associated zinc finger proteins LAZ-3/BCL-6 and PLZ-F, as well as in non-zinc finger proteins. C2H2-171 RNA is preferentially expressed in the brain, and increases during the course of murine development, with maximal expression in the adult. C2H2-171 RNA is differentially expressed in brain regions, with the highest level of expression in the cerebellum. C2H2-171 RNA was expressed at high levels in primary cerebellar granule cell neurons compared to astrocytes. The gene encoding C2H2-171 is highly conserved in vertebrates, and maps to the terminus of human chromosome 1 (1q44-ter). This chromosomal location is associated with a number of cytogenetic aberrations including those involving brain developmental anomalies and tumorigenesis. These data suggest that C2H2-171 may play an important role in vertebrate brain development and function. 相似文献
9.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
10.
Dr. D. Byron May Pharm.D.M Dr. Richard H. Drew M.S. Dr. Kimberly C. Yedinak Pharm.D. Dr. John A. Bartlett M.D. 《Pharmacotherapy》1994,14(5):509-513
Study Objective . To investigate the effect of simultaneously administered didanosine (ddI) on the absorption of a single dose of itraconazole. Design . Randomized, crossover, unblinded single-dose pharmacokinetic study in healthy volunteers. Comparisons of itraconazole alone and itraconazole with simultaneous ddI were performed on days 1 and 15. Setting . A university medical center. Patients . Seven healthy men and women. Six subjects (86%) completed the study; one was removed due to the development of a rash. Interventions . Volunteers received a single 200-mg oral dose of itraconazole or itraconazole with concomitant oral ddI 300 mg (two 150-mg tablets) dispersed in 240 ml water. Each regimen was separated by a 2-week washout period. Serum samples were obtained frequently for 12 hours after the dose. Measurements and Main Results . Concentrations of itraconazole were determined using a microbiologic assay. Individual concentrations in serum versus time data were evaluated by linear regression analysis. Peak serum concentration and time to peak were determined by visual inspection of each individual's serum concentration-time curve. A mean ± SD peak serum itraconazole concentration of 0.90 ± 0.30 μg/ml was observed at 3.0 ± 0.7 hours when itraconazole was administered alone, compared with undetectable levels in all patients during therapy with ddI. Conclusions . Simultaneous oral administration of ddI significantly decreases absorption of itraconazole. These drugs should not be administered concurrently. 相似文献